Schering-Plough Mergers & Acquisitions

Schering-Plough M&A Summary

Schering-Plough has acquired 5 companies of its own. It has also divested 1 asset.

Schering-Plough’s largest acquisition to date was in 2007, when it acquired Organon BioSciences N.V. for $12.4B. Schering-Plough has acquired in 4 different US states, and 2 countries. The Company’s most targeted sectors include life science (80%) and apparel/textiles (20%).

M&A Summary

  • M&A Total Activity6
    • M&A Buy Activity5
    • M&A Sell Activity1
  • Total Sectors Invested 2
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 2

Schering-Plough Corp.

2000 Galloping Hill Road,
Kenilworth, New Jersey 07033
United States,
(908) 298-4000
www.sch-plough.com

All (6) Buy (5) Sell (1)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2007-11-19 Organon BioSciences N.V. · Life Science
Oss, Netherlands

Organon BioSciences N.V. is a human health business, and Intervet, an animal health business. It also includes Nobilon, a human vaccine development unit, and Diosynth, a third-party manufacturing unit of Organon.

12,396 Divestiture

Schering-Plough Corp.

Akzo Nobel

-

Try Mergr Free — See This and 221,292+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 217K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.